Doctor profile · Federal record
Dr. GIANCARLO MERCOGLIANO, M.D.
Gastroenterology Physician · WYNNEWOOD, PA
- NPI 1144296013
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E LANCASTER AVE, LANKENAU MEDICAL BUILDING EAST SUITE 252
WYNNEWOOD, PA 190963450
(610) 896-7360
fax (610) 896-5207 - Mailing address
-
PO BOX 350
SELLERSVILLE, PA 189600350
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- November 2, 2007
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Pennsylvania #MD031568E
- Medicaid
- PA #0011489530004
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144296013. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
725
Distinct HCPCS
10
Medicare allowed
$101,922
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 150 | 140 | $93 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | 126 | $260 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 97 | 95 | $108 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 93 | 79 | $132 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 90 | 90 | $108 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 34 | 22 | $81 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 30 | 30 | $134 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 27 | 27 | $180 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 18 | 18 | $117 | |
G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | 17 | $189 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 111. This provider delivers 6.5× the peer median.Open Payments
Industry payments received
All-time total
$1,249
Transactions
62
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $334.74 | |
| ABBVIE INC. | 16 | $272.21 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110.55 | |
| Janssen Biotech, Inc. | 4 | $99.75 | |
| PFIZER INC. | 4 | $82.22 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $57.87 | |
| Lilly USA, LLC | 3 | $52.57 | |
| Madrigal Pharmaceuticals | 1 | $48.18 | |
| Celltrion USA Inc. | 1 | $24.60 | |
| Daiichi Sankyo Inc. | 1 | $24.59 | |
| GENZYME CORPORATION | 1 | $20.92 | |
| Ardelyx, Inc. | 1 | $20.32 | |
| Olympus America Inc. | 1 | $18.66 | |
| Gilead Sciences, Inc. | 1 | $17.86 | |
| Intercept Pharmaceuticals, Inc. | 1 | $17.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,045
Patients
222
Total drug cost
$1,668,191
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 338 | 83 | $3,904 |
| Pantoprazole Sodium | Generic | 201 | 57 | $3,172 |
| Famotidine | Generic | 121 | 35 | $1,640 |
| Mesalamine | Generic | 58 | 13 | $35,054 |
| Stelara (Ustekinumab) | Brand | 58 | 0 | $1,531,668 |
| Dicyclomine Hcl | Generic | 55 | 22 | $1,592 |
| Linzess (Linaclotide) | Brand | 45 | 12 | $28,505 |
| Lansoprazole | Generic | 42 | 0 | $7,417 |
| Esomeprazole Magnesium | Generic | 29 | 0 | $1,579 |
| Dexlansoprazole Dr (Dexlansoprazole) | Brand | 19 | 0 | $11,893 |